Did You Know?

Editor’s Picks

Latest News

Global 3D Printed Prosthetics Markets Report 2022:An $880 Million Market in 2021 with North America the Largest Region Followed by Asia-Pacific – Forecasts to 2026 & 2031

DUBLIN, June 24, 2022 /PRNewswire/ -- The "Global 3D Printed Prosthetics Market Report 2022" report has been added to ResearchAndMarkets.com's...

Amai Proteins, producer of 100% protein sweetener that reduces sugar in Food & Beverages by up to 70%, voted Global Winner at the 2022 Extreme Tech Challenge Competition

PALO ALTO, Calif., June 27, 2022 /PRNewswire/ -- Amai Proteins, an Israeli start-up developer of novel designer proteins that answer the...

Acer Therapeutics Announces Initiation of its Pivotal Phase 3 DiSCOVER Trial of EDSIVO™ (celiprolol) for the Treatment of Vascular Ehlers-Danlos Syndrome

NEWTON, Mass., June 27, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a clinical stage pharmaceutical company focused on...

Noema Pharma Announces FDA Investigational New Drug (IND) Authorization for Orpheus Phase 2b Study of PDE10A Inhibitor Gemlapodect (NOE-105) in Childhood Onset Fluency Disorder

Efficacy and safety study evaluating gemlapodect (NOE-105) in adults with Childhood Onset Fluency Disorder (also known as stuttering)Top-line data expected...

Enzyvant Receives 2022 Rare Impact Industry Innovation Award from the National Organization for Rare Disorders (NORD) for Novel, Tissue-Based Therapy to Treat Ultra-Rare, Life-Threatening Pediatric Condition

Company honored for its work on RETHYMIC® (allogeneic processed thymus tissue-agdc), a one-time, treatment for congenital athymia, an ultra-rare, severe...

error: Content is protected !!